Dr. Paul Beringer received his PharmD degree from USC Mann. He completed a pharmacy practice residency and specialty residency in pharmacokinetics at the University of California at San Francisco. He served as chair of the Titus Family Department of Clinical Pharmacy at USC Mann from 2017 to 2022. Currently, he is a professor of clinical pharmacy and associate professor of clinical medicine with the Department of Pulmonary and Critical Care Medicine at the Keck School of Medicine of USC. His clinical expertise is in the area of cystic fibrosis pharmacotherapy. He has authored numerous journal articles and book chapters in the area of pharmacokinetics and cystic fibrosis. He has been a principal investigator on a number of research studies on pharmacokinetics and pharmacodynamics of antimicrobial, anti-inflammatory, and CFTR modulator therapies. He has been awarded fellowship status with the American Society of Health-System Pharmacists (ASHP) and the American College of Clinical Pharmacy (FCCP). He currently serves as a pharmacy member on the NACFC planning committee. He is a member of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee (PSCP) of the FDA.